Abstract

CYCLOHEXIMIDE (‘Actidione’, Upjohn) is an antibiotic which inhibits growth of protozoa1, mammalian cells2 and many fungi3. It has been proposed that cells having strong aerobic fermentative capability are especially sensitive to this antibiotic4. In the present work, oxygen consumption and aerobic carbon dioxide evolution by 17 fungi grown in glucose medium was measured by standard manometric techniques5. Drug sensitivity was determined by the tube-dilution method. No correlation was found between respiratory quotient and susceptibility to cycloheximide (Table 1). Respiration and fermentation of glucose by Saccharomyces pastorianus were not inhibited appreciably by 2 µgm. cycloheximide/ml. although 0.5 µgm./ml. halted growth. Cells of S. pastorianus fermented maltose when cultivated in maltose medium, but not when cultivated in glucose medium. Fermentation by maltose-adapted cells was not retarded significantly by 2 µgm. antibiotic/ml. but the inductive process was suppressed completely (Table 2). Cells exposed to the drug were still viable at the end of the experiment. Cycloheximide does not inhibit significantly activity of glycolytic enzymes but does prevent new enzyme synthesis. Protein or nucleic acid synthesis, therefore, seems to be one vulnerable site of cycloheximide action6.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.